Skip to main content

Refine your results

Filters
Search
Include spaces in matter number if applicable. Ex.: 182 3125
Date
Displaying 13001 - 13020 of 44712
Advocacy Filings

Federal Trade Commission Comment Before the Federal Communications Commission Regarding the Privacy and Security Practices of Broadband Providers and Their Impact On Broadband Adoption

… Federal Trade Commission Comment Before the Federal Communications Commission Regarding the Privacy and Security Practices of Broadband … Comment Before the Federal Communications Commission Regarding the Privacy and Security Practices of Broadband …
Date
The FTC filed a comment before the Federal Communications Commission (FCC) in response to its inquiry into the status of broadband availability and deployment to all Americans, in which the FCC asked...
Related Release
FTC Provides Comment to Federal Communications Commission on Consumer Privacy and Data Security Issues and Broadband Internet Services
Early Termination Notices

20141525: AutoZone, Inc.; Dr. Karl Gaertner

… 20141525: AutoZone, Inc.; Dr. Karl Gaertner HSR Early Termination Notice 20141525: AutoZone, Inc.; Dr. Karl Gaertner 20141525 Interamerican Motor …
Date
Acquiring Party
AutoZone, Inc.
Acquired Party
Dr. Karl Gaertner
Acquired Entities
Interamerican Motor Corporation
CIM Investment Corporation
Early Termination Notices

20141531: Loews Corporation; Chevron Corporation

… Loews Corporation; Chevron Corporation HSR Early Termination Notice 20141531: Loews Corporation; Chevron Corporation 20141531 Chevron Petrochemical Pipeline LLC Chevron Corporation Loews Corporation … 20141531: …
Date
Acquiring Party
Loews Corporation
Acquired Party
Chevron Corporation
Acquired Entities
Chevron Petrochemical Pipeline LLC
Early Termination Notices

20141539: Sinclair Broadcast Group, Inc.; James E. Rogers Trust

… 20141539: Sinclair Broadcast Group, Inc.; James E. Rogers Trust HSR Early Termination Notice … Broadcast Group, Inc.; James E. Rogers Trust 20141539 Southern Nevada Communications, LLC James E. Rogers Trust …
Date
Acquiring Party
Sinclair Broadcast Group, Inc.
Acquired Party
James E. Rogers Trust
Acquired Entities
Southern Nevada Communications, LLC
Early Termination Notices

20141540: Calpine Corporation; Exelon Corporation

… 20141540: Calpine Corporation; Exelon Corporation HSR Early Termination Notice 20141540: Calpine Corporation; Exelon Corporation 20141540 Constellation …
Date
Acquiring Party
Calpine Corporation
Acquired Party
Exelon Corporation
Acquired Entities
Constellation Mystic Power, LLC
Early Termination Notices

20141542: Arthur T. Demoulas; Demoulas Super Markets, Inc.

… 20141542: Arthur T. Demoulas; Demoulas Super Markets, Inc. HSR Early Termination Notice 20141542: Arthur T. Demoulas; Demoulas Super Markets, Inc. 20141542 Demoulas Super Markets, Inc. Demoulas Super …
Date
Acquiring Party
Arthur T. Demoulas
Acquired Party
Demoulas Super Markets, Inc.
Acquired Entities
Demoulas Super Markets, Inc.
Early Termination Notices

20141543: Frances Irene Demoulas; Demoulas Super Markets, Inc.

… 20141543: Frances Irene Demoulas; Demoulas Super Markets, Inc. HSR Early Termination Notice 20141543: Frances Irene Demoulas; Demoulas Super Markets, Inc. 20141543 Demoulas Super Markets, Inc. Demoulas Super …
Date
Acquiring Party
Frances Irene Demoulas
Acquired Party
Demoulas Super Markets, Inc.
Acquired Entities
Demoulas Super Markets, Inc.
Cases and Proceedings

Akorn, Inc., In the Matter of

Akorn, Inc. has agreed to sell its rights to develop, manufacture, and market the generic injectable tuberculosis drug, rifampin, in order to settle FTC charges that Akorn’s proposed acquisition of VersaPharm Inc. and its parent company, VPI Holdings Corp., would likely be anticompetitive. According to the FTC’s complaint, only VersaPharm and two other firms currently have FDA approval to sell generic injectable rifampin and there are no viable substitutes for rifampin as a course of treatment for tuberculosis. The FTC’s proposed settlement with Akorn requires the company to divest its Abbreviated New Drug Application for generic injectable rifampin – which is currently pending before the Food and Drug Administration – to Watson Laboratories, Inc.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
141 0162
Displaying 13001 - 13020 of 44712
Return to top